JPRN-UMIN000016945已完成1 期
A phase I/II study of chemotherapy using Irinotecan, S-1 plus Oxaliplatin (IRISOX therapy) for unresectable pancreatic cancer - IRISOX therapy for unresectable pancreatic cancer
Department of Gastroenterology Kitasato University School of Medicine0 个研究点目标入组 25 人开始时间: 2015年3月27日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 25
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Patients with contraindication for the medication of Irinotecan, S-1 and L-OHP 2. History of serious drug hypersensitivity or a history of drug allergy 3. Pregnancy 4. Active infection 5. Severe complications 6. Peripheral neuropathy 7. Serious diarrhea 8. Intestinal pneumonitis or pulmonary fibrosis 9. Much ascites or pleural effusion or pericardial effusion 10. Active double cancer 11. Symptomatic brain metastasis 12. Regular use of frucitocin, fenitoin or warfarin 13. Having UGT1A1*6/*6, UGT1A1*28/*28, or UGT1A1*6/*28 gene 14. HBV carrier who has to take nucleotide analogues during chemotherapy 15. Inappropriate for this study judged by the attending physician
研究者
相似试验
招募中
不适用
A I/II phase study of chemotherapy using irinotecan plus L-OHP plus S-1 treatment (SOXIRI) for unresectable advanced pancreatic cancerunresectable advanced pancreatic cancerJPRN-UMIN000012975the university of tokushima30
已完成
不适用
A phase 2 neoadjuvant chemotherapy of Irinotecan (CPT-11) plus Nedaplatin (NDP) for stage 1b2 or 2 cervical cancer of the uterine cervixstage 1b2/2 cervical cancerJPRN-UMIN000000552Japanese Gynecologic Oncology Group65
已完成
不适用
Phase II study of concurrent chemotherapy with itraconazole in advanced gynecologic tumors.Gynecologic cancerJPRN-UMIN000013951Department of Obstetrics and Gynecology, Hyogo College of Medicine16
已完成
2 期
A phase ll study of adjuvant chemotherapy with Irinotecan (CPT-11) plus Nedaplatin (NDP) for stage lb2 or lla node-positive cervical cancerStage lb2 lla cervical cancer with pelvic lymph node metastasisJPRN-UMIN000003036Japanese Gynecologic Oncology Group63
进行中（未招募）
不适用
Metronomic chemiotherapic treatment WITH IRINOTECAN Cpt-11 IN PATIENTS WITH metastatic colon-rectal cancer PHARMACODYNAMIC And PHARMACOKINETIC evaluation. - CPTTS StudyColonrectal metatstatic cancerMedDRA version: 6.1Level: PTClassification code 10052358EUCTR2006-001045-34-ITAZIENDA USL 6 LIVORNO ZONA LIVORNESE18